Dual truncation of tau by caspase-2 accelerates its CHIP-mediated degradation
Lydia Reinhardt(Technische Universität Dresden), Dagmar E. Ehrnhoefer(AbbVie (Germany)), Jürgen Korffmann(AbbVie (Germany)), Ebru Ercan-Herbst(BioMed X Institute), Annika Behrendt(BioMed X Institute), Julia K. Mader(Medical University of Graz), Mélanie Schmitt(AbbVie (Germany)), Maria Bichmann(BioMed X Institute), Isabelle Becher, Fabrizio Musacchio(German Center for Neurodegenerative Diseases), David C. Schöndorf(Klinikum Ludwigshafen), Juliane Stein(AbbVie (Germany)), Martin Fuhrmann(German Center for Neurodegenerative Diseases), Christian Pohl(ETH Zurich), Per Haberkant(European Molecular Biology Organization), Corinna Klein(Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases), Laura Gasparini(University of Cambridge), Peter Reinhardt(AbbVie (United States)), Mikhail M. Savitski(European Molecular Biology Laboratory)
Cited by 6
Related Papers
Mass-spectrometry-based draft of the human proteome
|Nature|2014|1.9k
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
|Nature|2011|1.5k
Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present
|Analytical and Bioanalytical Chemistry|2012|801
Control of protein stability by post-translational modifications
|Nature Communications|2023|750